Clinical trial

Finasteride in Treating Patients With Stage II Prostate Cancer Who Are…

NCT00438464 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00438464
Title Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
Official title A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Lead sponsor National Cancer Institute (NCI), NIH
Collaborators M.D. Anderson Cancer Center
Status Completed
Phase Phase 2
Study type Interventional
Conditions Adenocarcinoma of the Prostate, Stage II Prostate Cancer
Intervention type Drug, Other, Procedure
Interventions Finasteride, Placebo, Prostatectomy, Laboratory biomarker analysis
Enrollment 204
Start date Feb 1, 2007
Primary completion Apr 1, 2012
Completion Apr 1, 2012
First posted Feb 22, 2007
Last update posted Mar 9, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies